Subhashini Chandrasekharan

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S155-70. 2010
  2. ncbi Impact of gene patents and licensing practices on access to genetic testing for hearing loss
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S171-93. 2010
  3. ncbi Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S194-211. 2010
  4. ncbi Gene patents and personalized medicine - what lies ahead?
    Subhashini Chandrasekharan
    Center for Public Genomics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genome Med 1:92. 2009
  5. ncbi Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers
    Robert Cook-Deegan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S15-38. 2010
  6. ncbi Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome
    Misha Angrist
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S111-54. 2010
  7. ncbi Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease
    Alessandra Colaianni
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S5-S14. 2010
  8. ncbi Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing
    Ashton Powell
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S83-S110. 2010

Collaborators

  • Misha Angrist
  • Robert Cook-Deegan
  • Ashton Powell
  • Alessandra Colaianni
  • Christopher DeRienzo
  • Christopher Heaney
  • Christopher Conover
  • Julia Carbone

Detail Information

Publications8

  1. ncbi Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S155-70. 2010
    ..This case study illustrates how both changes in intellectual property ownership and evolving clinical utility of HFE genetic testing in the last decade have effected the licensing of patents and availability of genetic testing...
  2. ncbi Impact of gene patents and licensing practices on access to genetic testing for hearing loss
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S171-93. 2010
    ..Clinicians have also expressed concerns that multiplex tests will be difficult to develop because of overlapping intellectual property and conflict with Athena's sole provider business model...
  3. ncbi Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis
    Subhashini Chandrasekharan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S194-211. 2010
    ..The Cystic Fibrosis Foundation has been engaged in licensing decisions, making cystic fibrosis a model of collaborative and cooperative patenting and licensing practice...
  4. ncbi Gene patents and personalized medicine - what lies ahead?
    Subhashini Chandrasekharan
    Center for Public Genomics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genome Med 1:92. 2009
    ....
  5. ncbi Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers
    Robert Cook-Deegan
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S15-38. 2010
    ..Myriad's sole-provider model has not worked in jurisdictions outside the United States, largely because of differences in breadth of patent protection, responses of government health services, and difficulty in patent enforcement...
  6. ncbi Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome
    Misha Angrist
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S111-54. 2010
    ....
  7. ncbi Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease
    Alessandra Colaianni
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S5-S14. 2010
    ....
  8. ncbi Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing
    Ashton Powell
    Center for Public Genomics, Center for Genome Ethics, Law and Policy, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA
    Genet Med 12:S83-S110. 2010
    ..In cases in which payers do not reimburse, the patient is responsible for payment, although some patients can apply to the voluntary Athena Access and Patient Protection Plan offered by the company...